Saldaña-Garrido Juan David, Cantó-Cerdán Mario, Gil-Guillén Vicente Francisco, Alfaro-Beltrá María Luisa, Sivera Francisca
Department of Ophthalmology, General University Hospital of Elda, Elda, Spain.
Department of Clinical Medicine, School of Medicine, Miguel Hernández de Elche University, San Juan de Alicante, Spain.
Front Med (Lausanne). 2024 Oct 15;11:1483930. doi: 10.3389/fmed.2024.1483930. eCollection 2024.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple systems and classified under connective tissue disorders. Ocular involvement occurs in up to 30% of SLE cases, with the cornea being particularly susceptible to thinning due to immune-complex deposits and its predominantly type I collagen composition. This corneal thinning is clinically significant in glaucoma, where patients with reduced central corneal thickness (CCT) may have up to a threefold increased risk of developing glaucoma, as well as in refractive surgery. However, existing studies on CCT in SLE are limited and marked by substantial heterogeneity in methodology, technology, criteria, and participant numbers, resulting in conflicting findings. Based in our hypothesis that SLE-related corneal lysis may result in decreased CCT, this study aims to determine and compare the mean CCT values between SLE patients and healthy controls to obtain a more precise understanding of the potential relationship.
A cross-sectional observational study will be conducted, enrolling SLE patients and age-and sex-matched healthy controls recruited from ophthalmology consultations. Exclusion criteria will be applied to rule out other corneal thinning risk factors. A pilot study estimated a minimum sample size of 34 participants per group. CCT measurements will be obtained using Zeiss HD Cirrus 5,000 optical coherence tomography (OCT) on a randomly selected eye, following concordance analysis using the Kappa index. Statistical analysis will include descriptive, bivariate, and multivariate methods. The study protocol was approved by the ethics committee.
The cornea's vulnerability to thinning and lysis in SLE, which impacts CCT, is crucial for the accurate assessment of glaucoma, the leading cause of irreversible blindness worldwide and the second leading cause in Europe. Given that patients with reduced CCT are at a significantly higher risk of developing glaucoma, further research is necessary to understand the association between SLE and CCT. Our study aims to enhance methodological rigor compared to prior research by determining an appropriate sample size and exclusively enrolling SLE patients to increase participant homogeneity. If a significant difference in CCT between groups and an association between CCT and SLE are found, a prospective study will be considered.
系统性红斑狼疮(SLE)是一种影响多个系统的慢性自身免疫性疾病,归类于结缔组织疾病。高达30%的SLE病例会出现眼部受累,由于免疫复合物沉积及其主要的I型胶原蛋白成分,角膜特别容易变薄。这种角膜变薄在青光眼以及屈光手术中具有临床意义,在青光眼中,中央角膜厚度(CCT)降低的患者患青光眼的风险可能会增加两倍,在屈光手术中也是如此。然而,现有关于SLE患者CCT的研究有限,且在方法、技术、标准和参与者数量方面存在很大异质性,导致结果相互矛盾。基于我们的假设,即SLE相关的角膜溶解可能导致CCT降低,本研究旨在确定并比较SLE患者与健康对照者的平均CCT值,以更准确地了解潜在关系。
将进行一项横断面观察性研究,招募从眼科会诊中选取的SLE患者以及年龄和性别匹配的健康对照者。将应用排除标准以排除其他角膜变薄风险因素。一项试点研究估计每组的最小样本量为34名参与者。使用蔡司HD Cirrus 5000光学相干断层扫描(OCT)在随机选择的一只眼睛上进行CCT测量,并使用Kappa指数进行一致性分析。统计分析将包括描述性、双变量和多变量方法。该研究方案已获得伦理委员会批准。
SLE中角膜易受变薄和溶解影响,进而影响CCT,这对于准确评估青光眼至关重要,青光眼是全球不可逆失明的主要原因,在欧洲是第二大主要原因。鉴于CCT降低的患者患青光眼的风险显著更高,有必要进一步研究以了解SLE与CCT之间的关联。与先前的研究相比,我们的研究旨在通过确定合适的样本量并专门招募SLE患者以提高参与者同质性来增强方法的严谨性。如果发现组间CCT存在显著差异以及CCT与SLE之间存在关联,则将考虑进行前瞻性研究。